Milliman
Pharmacy Trends Roundup: PBM Pharmacy Ownership Bans, GLP-1 Costs, and Drug Pricing Executive Order
Milliman's monthly pharmacy briefing covers state and federal PBM reform efforts (including Arkansas's ban on PBM-owned retail pharmacies and a multi-state push for similar federal action), a presidential executive order targeting drug pricing, a CMS decision not to cover anti-obesity drugs under certain programs, and rising GLP-1 drug spend trends. While focused mainly on commercial and Medicare pharmacy dynamics, these PBM regulatory shifts and drug cost trends carry indirect implications for Medicaid pharmacy benefit design and managed care drug spend management.
This is outside commentary from Milliman, not part of Medicaid Monitor's independently scored news coverage.